Rolf Hohlweg

418 total citations
17 papers, 344 citations indexed

About

Rolf Hohlweg is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rolf Hohlweg has authored 17 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rolf Hohlweg's work include Receptor Mechanisms and Signaling (8 papers), Mast cells and histamine (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Rolf Hohlweg is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Mast cells and histamine (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Rolf Hohlweg collaborates with scholars based in Denmark, Germany and Sweden. Rolf Hohlweg's co-authors include Kurt Heyns, Christian Thomsen, Peter H. Andersen, Karin Rimvall, Claus Bræstrup, Frederik C. Grønvald, Erik B. Nielsen, Jørgen Scheel‐Krüger, Jens Aas Jansen and Claus Jeppesen and has published in prestigious journals such as Journal of Neurochemistry, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Rolf Hohlweg

15 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf Hohlweg Denmark 10 217 164 92 60 25 17 344
Waisi Eng United States 13 250 1.2× 311 1.9× 43 0.5× 27 0.5× 51 2.0× 29 557
Kirsten L. Miller United States 10 191 0.9× 156 1.0× 59 0.6× 76 1.3× 100 4.0× 12 386
Lewis L. Truex United States 11 171 0.8× 184 1.1× 49 0.5× 19 0.3× 32 1.3× 18 389
Beatrice Garrone Italy 11 183 0.8× 152 0.9× 68 0.7× 57 0.9× 38 1.5× 25 434
D. E. BRUNDISH Switzerland 9 295 1.4× 315 1.9× 47 0.5× 27 0.5× 17 0.7× 16 479
Julie V. Selkirk United States 12 306 1.4× 291 1.8× 24 0.3× 19 0.3× 29 1.2× 23 497
Sylvain Célanire France 13 341 1.6× 216 1.3× 127 1.4× 169 2.8× 60 2.4× 24 572
Dieter Seidelmann Denmark 6 189 0.9× 190 1.2× 100 1.1× 32 0.5× 55 2.2× 10 499
Sandy Hufeisen United States 8 405 1.9× 255 1.6× 82 0.9× 13 0.2× 42 1.7× 10 626
M. S. NOBBS United Kingdom 10 312 1.4× 237 1.4× 181 2.0× 12 0.2× 40 1.6× 21 598

Countries citing papers authored by Rolf Hohlweg

Since Specialization
Citations

This map shows the geographic impact of Rolf Hohlweg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Hohlweg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Hohlweg more than expected).

Fields of papers citing papers by Rolf Hohlweg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Hohlweg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Hohlweg. The network helps show where Rolf Hohlweg may publish in the future.

Co-authorship network of co-authors of Rolf Hohlweg

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Hohlweg. A scholar is included among the top collaborators of Rolf Hohlweg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Hohlweg. Rolf Hohlweg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Malmlöf, Kjell, Sven Hastrup, Birgitte S. Wulff, et al.. (2007). Antagonistic targeting of the histamine H3 receptor decreases caloric intake in higher mammalian species. Biochemical Pharmacology. 73(8). 1237–1242. 25 indexed citations
2.
Peschke, Bernd, et al.. (2006). Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor. Bioorganic & Medicinal Chemistry Letters. 16(12). 3162–3165. 14 indexed citations
3.
Lau, Jesper, Claus Jeppesen, Karin Rimvall, & Rolf Hohlweg. (2006). Ureas with histamine H3-antagonist receptor activity—A new scaffold discovered by lead-hopping from cinnamic acid amides. Bioorganic & Medicinal Chemistry Letters. 16(20). 5303–5308. 24 indexed citations
4.
Malmlöf, Kjell, Rolf Hohlweg, & Karin Rimvall. (2006). Targeting of the central histaminergic system for treatment of obesity and associated metabolic disorders. Drug Development Research. 67(8). 651–665. 4 indexed citations
5.
Peschke, Bernd, et al.. (2004). Cinnamic amides of ( )-2-(aminomethyl)pyrrolidines are potent H3 antagonists. Bioorganic & Medicinal Chemistry. 12(10). 2603–2616. 21 indexed citations
7.
Sugamori, Kim S., et al.. (1998). Functional Differentiation of Multiple Dopamine D1‐Like Receptors by NNC 01‐0012. Journal of Neurochemistry. 71(4). 1685–1693. 9 indexed citations
8.
Scheideler, Mark A., Joel Martin, Rolf Hohlweg, et al.. (1997). The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain. European Journal of Pharmacology. 339(2-3). 261–270. 22 indexed citations
9.
Müller, Lars, Lars Farde, Rolf Hohlweg, et al.. (1995). Synthesis and binding properties of [3H]NNC 12-0781, a new radioligand for the dopamine reuptake system. Nuclear Medicine and Biology. 22(6). 711–717. 1 indexed citations
10.
Hohlweg, Rolf, et al.. (1995). Synthesis of Tricyclic Benzazepines and Their Dopamine D1- and D2-Affinity. Heterocycles. 41(11). 2441–2441.
11.
Halldin, Christer, Christian Foged, Per Karlsson, et al.. (1994). Preparation of a potential positron emission tomographic radioligand for the dopamine transporter. European Journal of Nuclear Medicine and Molecular Imaging. 21(2). 131–7. 10 indexed citations
12.
Andersen, Peter H., et al.. (1992). NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. European Journal of Pharmacology. 219(1). 45–52. 74 indexed citations
13.
Andersen, Peter H., et al.. (1987). Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists. European Journal of Pharmacology. 137(2-3). 291–292. 45 indexed citations
14.
Paulsen, Hans, Bernd Schröder, Henning Böttcher, & Rolf Hohlweg. (1981). Bausteine von Oligosacchariden, XXI1) Synthesen von Gentamicin X2 und am C‐4′ und C‐3′ modifizierter Gentamicine. Chemische Berichte. 114(1). 322–332. 7 indexed citations
15.
Heyns, Kurt & Rolf Hohlweg. (1978). [3.3]‐Sigmatrope Umlagerungen an Glycalen und Pseudoglycalen. Chemische Berichte. 111(4). 1632–1645. 42 indexed citations
16.
Heyns, Kurt & Rolf Hohlweg. (1978). Die Synthese von 2,3‐Diamino‐2,3‐didesoxy‐D‐glycosiden aus 3‐Azidoglycalen über ihre Nitrosylchlorid‐Addukte. Chemische Berichte. 111(12). 3912–3926. 7 indexed citations
17.
Heyns, Kurt, et al.. (1976). 2-C-verzweigte monosaccharidglykoside durch addition von orthoestern an glycale. Tetrahedron Letters. 17(18). 1481–1484.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026